Found: 28
Select item for more details and to access through your institution.
Lymphocytes NK : un rôle majeur dans le contrôle immunologique de la leucémie myéloïde chronique.
- Published in:
- Médecine Sciences, 2018, v. 34, n. 6/7, p. 540, doi. 10.1051/medsci/20183406013
- By:
- Publication type:
- Article
Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 451, doi. 10.1111/bjh.18542
- By:
- Publication type:
- Article
Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study).
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 175, doi. 10.1111/bjh.18486
- By:
- Publication type:
- Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
- By:
- Publication type:
- Article
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 337, doi. 10.1111/bjh.16083
- By:
- Publication type:
- Article
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 975, doi. 10.1111/bjh.13902
- By:
- Publication type:
- Article
Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 71, doi. 10.1111/bjh.14022
- By:
- Publication type:
- Article
Validation of the revised international prognostic scoring system ( IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS ( EUMDS) registry.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 372, doi. 10.1111/bjh.13450
- By:
- Publication type:
- Article
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 10, p. 2241, doi. 10.1007/s00277-022-04955-z
- By:
- Publication type:
- Article
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4695, doi. 10.3390/cancers14194695
- By:
- Publication type:
- Article
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1693, doi. 10.3390/cancers13071693
- By:
- Publication type:
- Article
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup>CD15<sup>−</sup> cells in early chronic‐phase chronic myeloid leukemia.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 6, p. 814, doi. 10.1002/1878-0261.12191
- By:
- Publication type:
- Article
Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 6, p. 3296, doi. 10.1002/cam4.2200
- By:
- Publication type:
- Article
Outcomes in RBC transfusion-dependent patients with Low-/ Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 5, p. 429, doi. 10.1111/ejh.12380
- By:
- Publication type:
- Article
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 9, p. 1774, doi. 10.1002/ccr3.3026
- By:
- Publication type:
- Article
The OPTIC Study: A Multicenter, Randomized, Phase 2 Trial to Evaluate Three Starting Doses of Ponatinib With Response-Based Dose Reduction in Patients with Chronic Phase Chronic Myeloid Leukemia Resistant to Prior Tyrosine Kinase Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S228, doi. 10.1016/j.clml.2018.07.104
- By:
- Publication type:
- Article
The OPTIC Study: a Multi-Center, Randomized Phase 2 Trial with Response-Based Dose Reduction to Evaluate Three Starting Doses of Ponatinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S59, doi. 10.1016/j.clml.2016.07.086
- By:
- Publication type:
- Article
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172147
- By:
- Publication type:
- Article
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
- Published in:
- Transfusion, 2022, v. 62, n. 5, p. 961, doi. 10.1111/trf.16884
- By:
- Publication type:
- Article
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 556, doi. 10.1002/ajh.23451
- By:
- Publication type:
- Article
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0491-2
- By:
- Publication type:
- Article
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid leukemia: Results with 24 months of follow-up.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 10, p. 1637, doi. 10.1002/cncr.29240
- By:
- Publication type:
- Article
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 5, p. 992, doi. 10.1002/cncr.25545
- By:
- Publication type:
- Article
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/ II Study by the GFM.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 2, p. 232, doi. 10.1111/j.1365-2141.2012.09153.x
- By:
- Publication type:
- Article
Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.
- Published in:
- Human Mutation, 2011, v. 32, n. 6, p. 590, doi. 10.1002/humu.21455
- By:
- Publication type:
- Article
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia.
- Published in:
- Turkish Journal of Hematology, 2023, v. 40, n. 2, p. 101, doi. 10.4274/tjh.galenos.2023.2022-0339
- By:
- Publication type:
- Article